Literature DB >> 35677497

Risk factors for necrotic cholecystitis during the COVID-19 pandemic: the ChoCO-WSES prospective collaborative study's experience.

Belinda de Simone1, Fausto Catena2, Salomone Di Saverio3, Massimo Sartelli4, Fikri M Abu-Zidan5, Mauro Podda6, Walter L Biffl7, Luca Ansaloni8, Federico Coccolini9, Ernest E Moore10, Yoram Kluger11, Carlos Augusto Gomes12, Ferdinando Agresta13, Elie Chouillard1.   

Abstract

Objectives: During the COVID-19 pandemic, several studies have reported a decrease in in the admission surgical patients and emergency surgical procedures, and an increase in more severe septic surgical diseases, such as necrotic cholecystitis. It was probably due to to a critical delay in time-to- diagnosis and time-to-intervention resulting to limited access to the operating theatres as well as intensive care units. Early laparoscopic cholecystec- tomy is the standard of care for acute cholecystitis. Moreover early data from COVID-19 pandemic reported an increase in the incidence of necrotic cholecystitis among COVID-19 patients. The ChoCO-W prospective observational collaborative study was conceived to investigate the incidence and management of acute cholecystitis under the COVID-19 pandemic. Material and
Methods: The present research protocol was. conceived and designed as a prospective observational international collaborative study focusing on the management of patients with to the diagnosis of acute cholecystitis under the COVID-19 pandemic. The study obtained the approval of the local Ethics Committee (Nimes, France) and meet and conform to the standards outlined in the Declaration of Helsinki. Eligible patients will be prospectively enrolled in the recruitment period and data entered in an online case report form.
Results: The ChoCO-W study will be the largest prospective study carried out during the first period of the COVID-19 pandemic with the aim to inves- tigate the management of patients with acute cholecystitis, in the lack of studies focusing on COVID-19 positive patients.
Conclusion: The ChoCO-W study is conceived to be the largest prospective study to assess the management of patients presenting with acute chol- ecystitis during the COVID-19 pandemic and risk factors correlated with necrotic cholecystitis to improve the management of high-risk patients.
Copyright © 2021, Turkish Surgical Society.

Entities:  

Keywords:  COVID-19; ChoCO-W; Cholecystitis; SARS-CoV-2; WSES; management

Year:  2021        PMID: 35677497      PMCID: PMC9130934          DOI: 10.47717/turkjsurg.2021.5507

Source DB:  PubMed          Journal:  Turk J Surg        ISSN: 2564-6850


  17 in total

1.  HUMAN EXPERIMENTATION. CODE OF ETHICS OF THE WORLD MEDICAL ASSOCIATION. DECLARATION OF HELSINKI.

Authors:  P P RICKHAM
Journal:  Br Med J       Date:  1964-07-18

2.  Risk factors for acute gangrenous cholecystitis in emergency general surgery patients.

Authors:  Seda Bourikian; Rahul J Anand; Michel Aboutanos; Luke G Wolfe; Paula Ferrada
Journal:  Am J Surg       Date:  2015-06-27       Impact factor: 2.565

Review 3.  Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis.

Authors:  Kohji Okamoto; Kenji Suzuki; Tadahiro Takada; Steven M Strasberg; Horacio J Asbun; Itaru Endo; Yukio Iwashita; Taizo Hibi; Henry A Pitt; Akiko Umezawa; Koji Asai; Ho-Seong Han; Tsann-Long Hwang; Yasuhisa Mori; Yoo-Seok Yoon; Wayne Shih-Wei Huang; Giulio Belli; Christos Dervenis; Masamichi Yokoe; Seiki Kiriyama; Takao Itoi; Palepu Jagannath; O James Garden; Fumihiko Miura; Masafumi Nakamura; Akihiko Horiguchi; Go Wakabayashi; Daniel Cherqui; Eduardo de Santibañes; Satoru Shikata; Yoshinori Noguchi; Tomohiko Ukai; Ryota Higuchi; Keita Wada; Goro Honda; Avinash Nivritti Supe; Masahiro Yoshida; Toshihiko Mayumi; Dirk J Gouma; Daniel J Deziel; Kui-Hin Liau; Miin-Fu Chen; Kazunori Shibao; Keng-Hao Liu; Cheng-Hsi Su; Angus C W Chan; Dong-Sup Yoon; In-Seok Choi; Eduard Jonas; Xiao-Ping Chen; Sheung Tat Fan; Chen-Guo Ker; Mariano Eduardo Giménez; Seigo Kitano; Masafumi Inomata; Koichi Hirata; Kazuo Inui; Yoshinobu Sumiyama; Masakazu Yamamoto
Journal:  J Hepatobiliary Pancreat Sci       Date:  2017-12-20       Impact factor: 7.027

4.  Clinical approach to patients admitted to the emergency room due to acute cholecystitis during the COVID-19 pandemic and percutaneous cholecystostomy experience.

Authors:  Hüseyin Çiyiltepe; Gülşah Yıldırım; Mehmet Mahir Fersahoğlu; M Timuçin Aydın; Yetkin Özcabı; Nuriye Esen Bulut; İksan Taşdelen; Ayşe Tuba Fersahoğlu; Zühal Demirhan Yananlı; İbrahim Aydın; Birol Ağca; Hakkı Muammer Karakaş; Umit Akyüz; Kemal Memisoğlu
Journal:  Ulus Travma Acil Cerrahi Derg       Date:  2020-12

5.  The management of surgical patients in the emergency setting during COVID-19 pandemic: the WSES position paper.

Authors:  Belinda De Simone; Elie Chouillard; Massimo Sartelli; Walter L Biffl; Salomone Di Saverio; Ernest E Moore; Yoram Kluger; Fikri M Abu-Zidan; Luca Ansaloni; Federico Coccolini; Ari Leppänemi; Andrew B Peitzmann; Leonardo Pagani; Gustavo P Fraga; Ciro Paolillo; Edoardo Picetti; Massimo Valentino; Emmanouil Pikoulis; Gian Luca Baiocchi; Fausto Catena
Journal:  World J Emerg Surg       Date:  2021-03-22       Impact factor: 5.469

6.  Post COVID 19 acute acalculous cholecystitis raising the possibility of underlying dysregulated immune response, a case report.

Authors:  Shahda Mohamed Alhassan; Phool Iqbal; Lubna Fikrey; Mohanad Ibrahim Mohamed Ibrahim; Muhammad Sohaib Qamar; Masautso Chaponda; Waqar Munir
Journal:  Ann Med Surg (Lond)       Date:  2020-11-13

7.  Gangrenous cholecystitis during hospitalization for SARS-CoV2 infection.

Authors:  Emanuele Asti; Andrea Lovece; Luigi Bonavina
Journal:  Updates Surg       Date:  2020-05-26

8.  Multicentre cohort study of acute cholecystitis management during the COVID-19 pandemic.

Authors:  Javier Martínez Caballero; Lucía González González; Elías Rodríguez Cuéllar; Eduardo Ferrero Herrero; Cristina Pérez Algar; Victor Vaello Jodra; María Dolores Pérez Díaz; Jana Dziakova; Rosario San Román Romanillos; Marcello Di Martino; Ángela de la Hoz Rodríguez; Mónica Galán Martín; Daniel Sánchez López; Mariana García Virosta; Marta de la Fuente Bartolomé; María de Mar Pardo de Lama; María Gutiérrez Samaniego; David Díaz Pérez; David Alias Jiménez; Luis de Nicolás Navas; Juan José Pérez Alegre; Javier García-Quijada García; Jenny Guevara-Martínez; Arantxa Villadoniga; Roberto Martínez Fernández
Journal:  Eur J Trauma Emerg Surg       Date:  2021-03-19       Impact factor: 3.693

9.  Acute cholecystitis during COVID-19 pandemic: a multisocietary position statement.

Authors:  Fabio Cesare Campanile; Mauro Podda; Alberto Arezzo; Emanuele Botteri; Alberto Sartori; Mario Guerrieri; Elisa Cassinotti; Irnerio Muttillo; Marcello Pisano; Riccardo Brachet Contul; Giancarlo D'Ambrosio; Diego Cuccurullo; Carlo Bergamini; Marco Ettore Allaix; Valerio Caracino; Wanda Luisa Petz; Marco Milone; Gianfranco Silecchia; Gabriele Anania; Antonino Agrusa; Salomone Di Saverio; Salvatore Casarano; Caterina Cicala; Piero Narilli; Sara Federici; Massimo Carlini; Alessandro Paganini; Paolo Pietro Bianchi; Adelona Salaj; Andrea Mazzari; Roberto Luca Meniconi; Alessandro Puzziello; Giovanni Terrosu; Belinda De Simone; Federico Coccolini; Fausto Catena; Ferdinando Agresta
Journal:  World J Emerg Surg       Date:  2020-06-08       Impact factor: 5.469

Review 10.  2020 World Society of Emergency Surgery updated guidelines for the diagnosis and treatment of acute calculus cholecystitis.

Authors:  Michele Pisano; Niccolò Allievi; Kurinchi Gurusamy; Giuseppe Borzellino; Stefania Cimbanassi; Djamila Boerna; Federico Coccolini; Andrea Tufo; Marcello Di Martino; Jeffrey Leung; Massimo Sartelli; Marco Ceresoli; Ronald V Maier; Elia Poiasina; Nicola De Angelis; Stefano Magnone; Paola Fugazzola; Ciro Paolillo; Raul Coimbra; Salomone Di Saverio; Belinda De Simone; Dieter G Weber; Boris E Sakakushev; Alessandro Lucianetti; Andrew W Kirkpatrick; Gustavo P Fraga; Imitaz Wani; Walter L Biffl; Osvaldo Chiara; Fikri Abu-Zidan; Ernest E Moore; Ari Leppäniemi; Yoram Kluger; Fausto Catena; Luca Ansaloni
Journal:  World J Emerg Surg       Date:  2020-11-05       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.